A new study has found that the blood pressure medication angiotensin-converting enzyme inhibitors (ACEIs) appear to reduce major cardiovascular events and death, as well death from all other causes, in patients with diabetes, while angiotensin II receptor blockers (ARBs) appear to have no such effect on those outcomes. strongAuthor:/strong Jun Cheng, M.D., of the Medical School of Zhejiang University, China, and colleagues. strongBackground:/strong ...
Read More
No comments:
Post a Comment